Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masami Takeuchi

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Leukemia & Lymphoma|April 4, 2022
Carfilzomib-induced thrombotic microangiopathy is underestimated in clinical practice: A report of five patients and literature reviewToshiki Terao, Takafumi Tsushima, Daisuke Miura, et al.
Blood Cancer Journal|September 4, 2023
Clinical and immunological characteristics of prolonged SARS-CoV-2 Omicron infection in hematologic diseaseDaisuke Ikeda, Ami Fukumoto, Yuka Uesugi, et al.
Oncotarget|February 8, 2019
Improved survival outcomes and relative youthfulness of multiple myeloma patients with t(4;14) receiving novel agents are associated with poorer performance of the revised international staging system in a real aging societyYoshiaki Abe, Kazutaka Sunami, Takeshi Yamashita, et al.
Blood|January 17, 2019
Sensitivity and specificity of incisional random skin biopsy for diagnosis of intravascular large B-cell lymphomaKosei Matsue, Yoshiaki Abe, Akihiro Kitadate, et al.
Clinical Nuclear Medicine|March 20, 2019
Diagnostic and Prognostic Value of Using 18F-FDG PET/CT for the Evaluation of Bone Marrow Involvement in Peripheral T-Cell LymphomaYoshiaki Abe, Akihiro Kitadate, Yoshiaki Usui, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 15, 2020
Light Chain Deposition Disease in a Patient With MYD88 L265P Mutation-positive Low-grade B-cell Lymphoma and Monoclonal Immunoglobulin G κKentaro Narita, Hiroki Kobayashi, Tomo Suzuki, et al.
International Journal of Hematology|December 2, 2025
Distinct immunophenotypic profiles of circulating tumor plasma cells in MGUS and smoldering multiple myelomaAtsushi Uehara, Kentaro Narita, Fuminari Fujii, et al.
Cancer Science|July 21, 2021
Multiple myeloma with t(11;14)-associated immature phenotype has lower CD38 expression and higher BCL2 dependenceAkihiro Kitadate, Toshiki Terao, Kentaro Narita, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 24, 2019
Low hexokinase-2 expression-associated false-negative <sup>18</sup>F-FDG PET/CT as a potential prognostic predictor in patients with multiple myelomaYoshiaki Abe, Sho Ikeda, Akihiro Kitadate, et al.
Frontiers in Oncology|May 17, 2021
Letermovir Administration to Prevent Cytomegalovirus Reactivation Is the Potential Risk of Chronic Graft-<i>Versus</i>-Host Disease in Patients Who Received Haploidentical Stem-Cell Transplantation With Post-Transplant CyclophosphamideToshiki Terao, Ken-Ichi Matsuoka, Kentaro Narita, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Leukemia & Lymphoma|April 4, 2022
Carfilzomib-induced thrombotic microangiopathy is underestimated in clinical practice: A report of five patients and literature reviewToshiki Terao, Takafumi Tsushima, Daisuke Miura, et al.
Blood Cancer Journal|September 4, 2023
Clinical and immunological characteristics of prolonged SARS-CoV-2 Omicron infection in hematologic diseaseDaisuke Ikeda, Ami Fukumoto, Yuka Uesugi, et al.
Oncotarget|February 8, 2019
Improved survival outcomes and relative youthfulness of multiple myeloma patients with t(4;14) receiving novel agents are associated with poorer performance of the revised international staging system in a real aging societyYoshiaki Abe, Kazutaka Sunami, Takeshi Yamashita, et al.
Blood|January 17, 2019
Sensitivity and specificity of incisional random skin biopsy for diagnosis of intravascular large B-cell lymphomaKosei Matsue, Yoshiaki Abe, Akihiro Kitadate, et al.
Clinical Nuclear Medicine|March 20, 2019
Diagnostic and Prognostic Value of Using 18F-FDG PET/CT for the Evaluation of Bone Marrow Involvement in Peripheral T-Cell LymphomaYoshiaki Abe, Akihiro Kitadate, Yoshiaki Usui, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 15, 2020
Light Chain Deposition Disease in a Patient With MYD88 L265P Mutation-positive Low-grade B-cell Lymphoma and Monoclonal Immunoglobulin G κKentaro Narita, Hiroki Kobayashi, Tomo Suzuki, et al.
International Journal of Hematology|December 2, 2025
Distinct immunophenotypic profiles of circulating tumor plasma cells in MGUS and smoldering multiple myelomaAtsushi Uehara, Kentaro Narita, Fuminari Fujii, et al.
Cancer Science|July 21, 2021
Multiple myeloma with t(11;14)-associated immature phenotype has lower CD38 expression and higher BCL2 dependenceAkihiro Kitadate, Toshiki Terao, Kentaro Narita, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 24, 2019
Low hexokinase-2 expression-associated false-negative <sup>18</sup>F-FDG PET/CT as a potential prognostic predictor in patients with multiple myelomaYoshiaki Abe, Sho Ikeda, Akihiro Kitadate, et al.
Frontiers in Oncology|May 17, 2021
Letermovir Administration to Prevent Cytomegalovirus Reactivation Is the Potential Risk of Chronic Graft-<i>Versus</i>-Host Disease in Patients Who Received Haploidentical Stem-Cell Transplantation With Post-Transplant CyclophosphamideToshiki Terao, Ken-Ichi Matsuoka, Kentaro Narita, et al.
Pageof 12